- Delivering Pan India
Venclyxto® (Venetoclax) Venetoclax 100 mg film-coated tablets by AbbVie. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Venetoclax 100 mg |
|---|---|
| Manufacturer | AbbVie |
| Country | Ireland |
| Pack size | Venetoclax 100 mg: Please confirm the pack supplied (the carton shown is a multipack) |
| Storage | As per carton and leaflet; original pack |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Venclyxto® (Venetoclax) Venetoclax 100 mg Film-Coated Tablets — BCL-2 Inhibitor: A Sourcing Guide for Hospitals and Oncology Pharmacies
Venclyxto® is the European brand name of venetoclax film-coated tablets, an oral BCL-2 inhibitor marketed by AbbVie (sold in the US as Venclexta®). According to the US prescribing information for the reference product (Venclexta), venetoclax is indicated for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), and, in combination with azacitidine, decitabine or low-dose cytarabine, for newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older or with comorbidities that preclude intensive induction chemotherapy. Indications for Venclyxto in India are defined by its approved pack insert and the Indian regulator. The decision to prescribe venetoclax, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Venclyxto® (venetoclax) Venetoclax 100 mg film-coated tablets to hospitals, oncology centres and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the cancer medicines category. Supply is in bulk/wholesale quantities only.
Venclyxto contains venetoclax, an oral BCL-2 inhibitor, supplied as film-coated tablets. The Venclyxto carton shown on this page states 100 mg tablets.
How it works, according to the label: The reference label describes venetoclax as a BCL-2 inhibitor and gives prominent warnings about tumor lysis syndrome, which is why the label calls for risk assessment and prophylaxis by the treating physician.
The current US prescribing information for VENCLEXTA® (venetoclax tablets) (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Venclyxto pack insert.
The Venclexta label summarises its Clinical Studies by indication, including the MURANO trial in relapsed or refractory CLL (venetoclax with rituximab; Seymour et al., New England Journal of Medicine, 2018) and the VIALE-A trial in previously untreated AML (venetoclax with azacitidine; DiNardo et al., New England Journal of Medicine, 2020). Full results are in the DailyMed prescribing information. Evidence is cited for information only and is not a recommendation for any patient; the approved prescribing information governs.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Venetoclax 100 mg | Film-coated tablets (oral) | Please confirm the pack supplied (the carton shown is a multipack) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
This page is written for hospital pharmacists, haemato-oncology department buyers and pharmacies that source oral oncology products. Venetoclax is prescribed and supervised by a physician, as described in the prescribing information.
The Venclexta label lists, as most common adverse reactions (20% or more), neutropenia, thrombocytopenia, anemia, diarrhea, nausea, upper respiratory tract infection, cough, musculoskeletal pain, fatigue and edema. Its warnings cover tumor lysis syndrome, neutropenia, infections, embryo-fetal toxicity and the need for caution with live vaccines. This list is not complete; the full prescribing information governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Venclyxto carton and leaflet. The US label (Venclexta) describes storage at or below 30°C; confirm against the pack supplied. Keep in the original pack, out of reach of children.
Venclyxto is marketed by AbbVie. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Venclyxto through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Venclyxto available in India?
A.K. Pharma supplies Venclyxto (venetoclax) Venetoclax 100 mg film-coated tablets to hospitals and pharmacies in India. Contact us for current availability.
What does Venclyxto contain?
Venetoclax, an oral BCL-2 inhibitor, as 100 mg film-coated tablets.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Venclyxto be stored?
As printed on the carton and leaflet, in the original pack.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
